Replies to post #31999 on Ariad Pharmaceuticals Inc fka ARIA

[Moanrch]

http://www.pmlive.com/pharma_news/nice_novartis_tasigna_glivec_bms_sprycel_cml_395458

[jaybe]

By the way HB's $3M booked in France was at the already assumed reduced price for EU. For my purpose I'm assuming EU price at 3/4 US, so $86k per year, and with a 150% US market size, sales will be double current ramp by mid-2014.

Sprinkle a little early EPIC efficacy on that and you see how we can have positive EPS in 3rd quarter of 2014.